Gordon-Smith E C
Division of Haematology, St. George's Hospital Medical School, London, UK.
Bone Marrow Transplant. 1989 Dec;4 Suppl 4:118-20.
Bone marrow transplantation is the first line of treatment for all patients with aplastic anaemia who have an identical twin. Age is not an important consideration in these circumstances. For patients with an HLA identical sibling donor bone marrow transplantation should be offered as a matter of urgency to those patients with SAA under the age of 50. The most controversial issue is the use of unrelated volunteers, or non-sibling family members who are phenotypically matched or who have a minor degree of mismatch of the HLA system. A strong case could be made for offering this form of transplant to all patients under the age of 20 who have VSAA and using it as the second line of treatment in patients who fail to respond to ALG after 4 months if they have VSAA.
对于所有患有再生障碍性贫血且有同卵双胞胎的患者,骨髓移植是首选治疗方法。在这种情况下,年龄不是重要的考虑因素。对于有 HLA 匹配同胞供体的患者,对于年龄在 50 岁以下的重型再生障碍性贫血患者,应紧急进行骨髓移植。最具争议的问题是使用无关志愿者或表型匹配或 HLA 系统有轻微错配的非同胞家庭成员。对于所有 20 岁以下患有非常重型再生障碍性贫血的患者,可以有力地证明提供这种形式的移植,并将其作为患有非常重型再生障碍性贫血且在 4 个月后对抗淋巴细胞球蛋白无反应的患者的二线治疗方法。